Biotech Values

[urche]

"How did everyone do in 2004? "

I really appreciate the candor of those willing to share their successes, failures, luck, and foolishness--a good way to learn.
In that spirit here is a summary of the movers for me:
The only gains >50% were in MEDX and IIF (Indian ETF).
Also did well with JNJ which has been converted to PFE.
Also good for about 30% gains was playing the ups and downs of two Canadian energy trusts which make it easy by sporting 12-18% dividend yields.

The biggest losers have been Conceptus and GTCB, both of which I still hold and feel guardedly optimistic if not excited about prospects for 2-3 years from now.
The next biggest loser for me was Nastech and the reason was just terrible timing, losing confidence and selling just before it made a major breakthrough in partnership for PYY. That was my most crushing loss emotionally.

Have not figured gain for the year, but probably in 15-30% range.

Now, biggest biotech holdings are Spectrum, GTCB, and MEDX (which has almost overtaken GTCB).

Best wishes and thanks to all for sharing.

Urche